Synergistic Co-Targeting of BTK and BCL2 in Mantle Cell Lymphoma

被引：1

作者：

Li, Yangguang ^{[1
]}

Bouchlaka, Myriam N. ^{[2
,3
]}

Grindle, Kreg ^{[1
]}

Kahl, Brad S. ^{[4
]}

Miyamoto, Shigeki ^{[5
]}

Yang, David T. ^{[6
]}

Capitini, Christian M. ^{[7
]}

Rui, Lixin ^{[8
,9
]}

机构：

[1] Dept Med, Madison, WI USA

[2] Univ Madison, Dept Pediat, Madison, WI USA

[3] Univ Madison, Carbone Canc Ctr, Madison, WI USA

[4] Washington Univ, St Louis, MO USA

[5] Dept Oncol, Madison, WI USA

[6] Carbone Canc Ctr, Madison, WI USA

[7] Univ Wisconsin, Dept Pediat, Madison, WI USA

[8] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA

[9] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[11] Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways
Zhao, Xiaoxian
Bodo, Juraj
Sun, Danyu
Durkin, Lisa
Lin, Jeffrey
Smith, Mitchell R.
Hsi, Eric D.
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (05) : 765 - 768
[12] Dual targeting of BTK and PLK1 causes lethal synergistic effects in mantle cell lymphoma
Jiang, Changying
Huang, Shengjian
Liu, Yang
Nomie, Krystle
Zhang, Leo
Wang, Michael
CANCER RESEARCH, 2018, 78 (13)
[13] Synergistic Cytotoxicity of Bendamustine and the BTK Inhibitor in a Mantle Cell Lymphoma Cell Line
Hagiwara, Kazumi
Tokunaga, Takashi
Iida, Hiroatsu
Nagai, Hirokazu
ANTICANCER RESEARCH, 2015, 35 (12) : 6679 - 6684
[14] Bcl2 (B cell lymphoma)
不详
BULLETIN DU CANCER, 1998, 85 (09) : 738 - 738
[15] Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Wang, Michael L.
Rule, Simon
Martin, Peter
Goy, Andre
Auer, Rebecca
Kahl, Brad S.
Jurczak, Wojciech
Advani, Ranjana H.
Romaguera, Jorge E.
Williams, Michael E.
Barrientos, Jacqueline C.
Chmielowska, Ewa
Radford, John
Stilgenbauer, Stephan
Dreyling, Martin
Jedrzejczak, Wieslaw Wiktor
Johnson, Peter
Spurgeon, Stephen E.
Li, Lei
Zhang, Liang
Newberry, Kate
Ou, Zhishuo
Cheng, Nancy
Fang, Bingliang
McGreivy, Jesse
Clow, Fong
Buggy, Joseph J.
Chang, Betty Y.
Beaupre, Darrin M.
Kunkel, Lori A.
Blum, Kristie A.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (06): : 507 - 516
[16] Single Cell Transcriptomic Evolution and Resistance Mechanisms of BTK and BCL-2 Inhibition in Mantle Cell Lymphoma
Jiang, Vivian Changying
Zhang, Shaojun
Lian, Junwei
Wang, Yuanxin
Zhang, Rongjia
Liu, Yang
McIntosh, Joseph
Han, Guangchun
Wang, Ruiping
Santos, David
Badillo, Maria
Leeming, Angela
Chen, Zhihong
Hartig, Kimberly
Bigcal, John
Lee, Hun
Steiner, Raphael Eric
Romaguera, Jorge Enrique
Jain, Preetesh
Nomie, Krystle
Futreal, Andy
Wang, Linghua
Wang, Michael
BLOOD, 2020, 136
[17] Co-targeting of MYC and BCL2 signaling is a promising treatment strategy for double hit and triple hit B-cell lymphomas
Cinar, Munevver
Rosenfelt, Fred
Rokshar, Sepehr
Pillai, Raju
Lopategui, Jean
Cervania, Melissa
Cinar, Bekir
Alkan, Serhan
MOLECULAR CANCER RESEARCH, 2015, 13
[18] SOX11 Inhibits BCR Signaling Through the PAX5/CD19 Axis for Therapeutic Targeting in BTK and BCL2 Inhibitor Resistant Mantle Cell Lymphoma
Dutta, Rudra Prasad
Lee, Heng-Huan
Leshchenko, Violetta V.
Shukla, Ravi Prakash
Liu, Yang
Reci, Sidorela
Grossman, Leah
Jin, Jian
Wang, Michael
Parekh, Samir
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S518 - S519
[19] Impact of BCL2 Mutations to BCL2 Protein Expression in B-Cell Lymphoma
Baik, Jeeyeon
Isgor, Irem
Aypar, Umut
Dogan, Ahmet
LABORATORY INVESTIGATION, 2023, 103 (03) : S1096 - S1097
[20] Bcl2 expression predicts better overall survival in 90 patients with mantle cell lymphoma.
Schrader, C
Klapper, W
Janssen, D
Riis, P
Meusers, P
Brittinger, G
Siebmann, JU
Kneba, M
Parwaresch, R
BLOOD, 2005, 106 (11) : 249B - 249B

← 1 2 3 4 5 →